相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
Giovanni Targher et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
HYPOXIA AND ADIPOSE TISSUE FUNCTION AND DYSFUNCTION IN OBESITY
Paul Trayhurn
PHYSIOLOGICAL REVIEWS (2013)
Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit
Annamaria Morelli et al.
PROSTATE (2013)
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
Luciano Adorini et al.
DRUG DISCOVERY TODAY (2012)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit
Linda Vignozzi et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements
Elena Maneschi et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome
Annamaria Morelli et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Update on perilipin polymorphisms and obesity
Caren E. Smith et al.
NUTRITION REVIEWS (2012)
Insulin-sensitive obesity in humans - a 'favorable fat' phenotype?
D. Samocha-Bonet et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells
R. W. O'Rourke et al.
DIABETOLOGIA (2011)
Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes
Linda Vignozzi et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome - An allostatic perspective
Sam Virtue et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
The bile acid sensor FXR regulates insulin transcription and secretion
Barbara Renga et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
A fresh look at NASH pathogenesis. Part 1: The metabolic movers
Claire Z. Larter et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
Sabrina Cipriani et al.
JOURNAL OF LIPID RESEARCH (2010)
Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
Giovanni Rizzo et al.
MOLECULAR PHARMACOLOGY (2010)
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders
Stefano Fiorucci et al.
PROGRESS IN LIPID RESEARCH (2010)
Inflammation and impaired adipogenesis in hypertrophic obesity in man
Birgit Gustafson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Charles Thomas et al.
CELL METABOLISM (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
The liver and the waistline: Fifty years of growth
Geoffrey C. Farrell
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity
Roberto Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Testosterone Partially Ameliorates Metabolic Profile and Erectile Responsiveness to PDE5 Inhibitors in an Animal Model of Male Metabolic Syndrome
Sandra Filippi et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Targeting bile-acid signalling for metabolic diseases
Charles Thomas et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis
Dawn L. Brasaemle
JOURNAL OF LIPID RESEARCH (2007)
Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea
Hiroyuki Sato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity
Pontus Bostrom et al.
NATURE CELL BIOLOGY (2007)
Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual
N. Franck et al.
DIABETOLOGIA (2007)
Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages
James A. Timmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Abdominal obesity and metabolic syndrome
Jean-Pierre Despres et al.
NATURE (2006)
The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo
Giovanni Rizzo et al.
MOLECULAR PHARMACOLOGY (2006)
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
B Cariou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor γ
DA Sarruf et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
KL Donnelly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Minireview: Cyclin D1: Normal and abnormal functions
MF Fu et al.
ENDOCRINOLOGY (2004)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
Role of SNAP23 in insulin-induced translocation of GLUT4 in 3T3-L1 adipocytes - Mediation of complex formation between syntaxin4 and VAMP2
M Kawanishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
